UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +6.7% ·
share flow -3.6% ·
net new positions +6.2%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +4 | 28.21M | $15.29B | +8 | −3 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | — |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | — | — |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | — |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | — | — |
| Q2 2024 | 14 | — | 8.17M | $2.60B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.23M | +1.4% | $687.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 2.11M | +0.8% | $649.52M | 1.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.03M | -17.8% | $624.68M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 1.22M | +7.5% | $377.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 1.22M | +7.5% | $377.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 908.45K | -6.9% | $273.31M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 908.45K | -6.9% | $273.31M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 908.45K | -6.9% | $273.31M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 908.45K | -6.9% | $273.31M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 18 | Norges Bank ✦ (passive) | 466.35K | +8.4% | $143.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 398.23K | -26.6% | $122.76M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 20 | Marshall Wace ✦ | 213.00K | New | $65.66M | 0.1% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 213.00K | New | $65.66M | 0.1% | New | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 213.00K | New | $65.66M | 0.1% | New | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 193.78K | +79.9% | $59.74M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 189.73K | -52.3% | $58.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 189.73K | -52.3% | $58.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 89.34K | +46.0% | $27.54M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 36.18K | +77.9% | $11.15M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 30.27K | -30.1% | $9.33M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 30.27K | -30.1% | $9.33M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 30 | Fisher Asset Management ✦ | 18.59K | +13.8% | $5.73M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Millennium Management ✦ | 4.04K | -85.6% | $1.24M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 32 | Two Sigma Investments ✦ | 1.52K | -14.0% | $470,112 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $65.66M | 0.1% |
| Marshall Wace | $65.66M | 0.1% |
| Marshall Wace | $65.66M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 218.70K shares, $129,684 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 1.32K sh · $675,421
Officer, Director · 3.59K sh · $1.84M
Officer, Director · 224 sh · $114,108
Officer, Director · 3.06K sh · $1.56M
Officer, Director · 1.30K sh · $669,921
Officer, Director · 773 sh · $399,695
Officer, Director · 235 sh · $123,474
Officer, Director · 455 sh · $238,247
Officer, Director · 669 sh · $349,411
Officer, Director · 271 sh · $139,254
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology